| 1 |
Isobolographic analysis of the antidepressant interaction in two-drug combinations of citalopram, bupropion, and scopolamine in mice |
|
| | Mohammad-Hossein Mohammadi-Mahdiabadi-Hasani, Mohaddeseh Ebrahimi-Ghiri, Fatemeh Khakpai, Mohammad-Reza Zarrindast | | | Naunyn-Schmiedeberg's Archives of Pharmacology. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
The Potential Antidepressant Action of Duloxetine Co-Administered with the TAAR1 Receptor Agonist SEP-363856 in Mice |
|
| | Xia Ren, Jiaying Xiong, Lingzhi Liang, Yin Chen, Guisen Zhang | | | Molecules. 2022; 27(9): 2755 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Do greater levels of in-cage waking inactivity in laboratory mice reflect a spontaneous depression-like symptom? A pharmacological investigation |
|
| | Carole Fureix, Anna C. Trevarthen, Emily M. Finnegan, Katarína Bucková, Elizabeth S. Paul, Michael T. Mendl | | | Pharmacology Biochemistry and Behavior. 2021; : 173311 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Pindolol potentiates the antidepressant effect of venlafaxine by inhibiting 5-HT1A receptor in DRN neurons of mice |
|
| | Burak Yaman, Ramazan Bal | | | International Journal of Neuroscience. 2020; : 1 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics |
|
| | Stephanie C. Dulawa, David S. Janowsky | | | Molecular Psychiatry. 2019; 24(5): 694 | | | [Pubmed] [Google Scholar] [DOI] | |
|
